BlackRock Investment Management’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$5.52M Buy
167,949
+31,227
+23% +$1.03M 0.01% 1525
2016
Q3
$4.31M Buy
136,722
+1,462
+1% +$46.1K 0.01% 1584
2016
Q2
$3.8M Buy
135,260
+13,675
+11% +$385K ﹤0.01% 1627
2016
Q1
$4.42M Buy
121,585
+3,138
+3% +$114K 0.01% 1454
2015
Q4
$4.74M Buy
118,447
+1,114
+0.9% +$44.6K 0.01% 1430
2015
Q3
$3.34M Sell
117,333
-1,848
-2% -$52.7K ﹤0.01% 1663
2015
Q2
$3.93M Buy
119,181
+12,071
+11% +$398K ﹤0.01% 1690
2015
Q1
$3.08M Buy
107,110
+1,261
+1% +$36.3K ﹤0.01% 1726
2014
Q4
$2.88M Sell
105,849
-1,418
-1% -$38.6K ﹤0.01% 1749
2014
Q3
$2.29M Buy
107,267
+1,311
+1% +$27.9K ﹤0.01% 1895
2014
Q2
$2.38M Sell
105,956
-845
-0.8% -$19K ﹤0.01% 1940
2014
Q1
$2.7M Buy
106,801
+1,299
+1% +$32.8K ﹤0.01% 1817
2013
Q4
$2.43M Sell
105,502
-1,680
-2% -$38.6K ﹤0.01% 1876
2013
Q3
$2.04M Buy
107,182
+4,308
+4% +$82.1K ﹤0.01% 1939
2013
Q2
$1.48M Buy
+102,874
New +$1.48M ﹤0.01% 2076